AAPL343.01-0.90 (-0.26%) ▼|ABBV286.49-0.37 (-0.13%) ▼|ABT103.75-1.13 (-1.08%) ▼|ACN237.94-9.29 (-3.76%) ▼|ADBE251.84-6.78 (-2.62%) ▼|AMAT387.39-0.21 (-0.05%) ▼|AMD546.64+15.36 (+2.89%) ▲|AMGN445.45+0.82 (+0.18%) ▲|AMT187.21-1.08 (-0.57%) ▼|AMZN249.64+0.55 (+0.22%) ▲|AVGO337.32+8.15 (+2.48%) ▲|AXP313.64-1.41 (-0.45%) ▼|BA185.35-2.96 (-1.57%) ▼|BAC50.66+0.14 (+0.27%) ▲|BKNG151.00-2.14 (-1.40%) ▼|BLK1,131.08+3.42 (+0.30%) ▲|BMY61.33-0.28 (-0.45%) ▼|BNY147.54+0.36 (+0.24%) ▲|BRK-B544.92-3.64 (-0.66%) ▼|C122.83+1.79 (+1.48%) ▲|CAT703.11+10.98 (+1.59%) ▲|CL92.53-0.58 (-0.62%) ▼|CMCSA22.00-0.05 (-0.23%) ▼|COF202.51+0.16 (+0.08%) ▲|COP149.88-1.49 (-0.98%) ▼|COST997.30-7.86 (-0.78%) ▼|CRM242.68-4.93 (-1.99%) ▼|CSCO110.34+0.10 (+0.09%) ▲|CVS92.46-0.07 (-0.08%) ▼|CVX230.49-1.52 (-0.66%) ▼|DE650.76+9.51 (+1.48%) ▲|DHR231.87-1.10 (-0.47%) ▼|DIS109.83-0.57 (-0.52%) ▼|DUK124.33-0.11 (-0.09%) ▼|EMR163.10+1.40 (+0.87%) ▲|FDX304.14+3.56 (+1.18%) ▲|GD355.79-1.25 (-0.35%) ▼|GE293.40+4.97 (+1.72%) ▲|GEV874.06+19.44 (+2.27%) ▲|GILD157.38-1.31 (-0.83%) ▼|GM80.10+3.79 (+4.96%) ▲|GOOG314.70+0.51 (+0.16%) ▲|GOOGL318.22+1.42 (+0.45%) ▲|GS911.06+17.78 (+1.99%) ▲|HD317.96-1.43 (-0.45%) ▼|HON217.21-2.07 (-0.94%) ▼|IBM250.80-2.64 (-1.04%) ▼|INTC92.22+1.75 (+1.93%) ▲|INTU330.60-9.29 (-2.73%) ▼|ISRG449.42-2.21 (-0.49%) ▼|JNJ267.30+1.00 (+0.38%) ▲|JPM336.32+2.28 (+0.68%) ▲|KO92.66-0.04 (-0.04%) ▼|LIN507.34-0.22 (-0.04%) ▼|LLY1,286.81+7.67 (+0.60%) ▲|LMT631.64-3.56 (-0.56%) ▼|LOW196.11-2.12 (-1.07%) ▼|LRCX237.11-0.40 (-0.17%) ▼|MA607.87-5.63 (-0.92%) ▼|MCD248.95-1.88 (-0.75%) ▼|MDLZ62.44-0.53 (-0.84%) ▼|MDT94.11-0.68 (-0.72%) ▼|META621.64-8.92 (-1.41%) ▼|MMM172.09-0.70 (-0.41%) ▼|MO73.20-0.43 (-0.58%) ▼|MRK140.82+0.21 (+0.15%) ▲|MS186.22+2.73 (+1.49%) ▲|MSFT528.97-3.63 (-0.68%) ▼|MU914.58+10.88 (+1.20%) ▲|NEE82.20+0.16 (+0.20%) ▲|NFLX63.06-0.85 (-1.32%) ▼|NKE37.74-0.17 (-0.45%) ▼|NOW154.24-3.94 (-2.49%) ▼|NVDA215.85-0.15 (-0.07%) ▼|ORCL129.92+3.86 (+3.06%) ▲|PEP134.52-0.94 (-0.69%) ▼|PFE29.72-0.08 (-0.25%) ▼|PG159.07-0.86 (-0.53%) ▼|PLTR197.40-1.44 (-0.72%) ▼|PM203.35+1.48 (+0.73%) ▲|QCOM179.64+0.04 (+0.02%) ▲|RTX196.97-0.52 (-0.26%) ▼|SBUX101.44-1.26 (-1.22%) ▼|SCHW89.59-0.14 (-0.16%) ▼|SO91.96-0.62 (-0.66%) ▼|SPG211.59-1.10 (-0.52%) ▼|T20.95+0.10 (+0.46%) ▲|TMO688.36+3.47 (+0.51%) ▲|TMUS146.97+0.04 (+0.03%) ▲|TSLA401.33+9.71 (+2.48%) ▲|TXN302.37+4.25 (+1.43%) ▲|UBER65.67-0.46 (-0.70%) ▼|UNH411.41+0.71 (+0.17%) ▲|UNP296.79-0.18 (-0.06%) ▼|UPS103.16+2.84 (+2.83%) ▲|USB59.23-0.48 (-0.80%) ▼|V399.42-4.74 (-1.17%) ▼|VZ43.27+0.17 (+0.39%) ▲|WFC82.30-0.36 (-0.43%) ▼|WMT119.23-1.06 (-0.88%) ▼|XOM182.01-2.53 (-1.37%) ▼|AAPL343.01-0.90 (-0.26%) ▼|ABBV286.49-0.37 (-0.13%) ▼|ABT103.75-1.13 (-1.08%) ▼|ACN237.94-9.29 (-3.76%) ▼|ADBE251.84-6.78 (-2.62%) ▼|AMAT387.39-0.21 (-0.05%) ▼|AMD546.64+15.36 (+2.89%) ▲|AMGN445.45+0.82 (+0.18%) ▲|AMT187.21-1.08 (-0.57%) ▼|AMZN249.64+0.55 (+0.22%) ▲|AVGO337.32+8.15 (+2.48%) ▲|AXP313.64-1.41 (-0.45%) ▼|BA185.35-2.96 (-1.57%) ▼|BAC50.66+0.14 (+0.27%) ▲|BKNG151.00-2.14 (-1.40%) ▼|BLK1,131.08+3.42 (+0.30%) ▲|BMY61.33-0.28 (-0.45%) ▼|BNY147.54+0.36 (+0.24%) ▲|BRK-B544.92-3.64 (-0.66%) ▼|C122.83+1.79 (+1.48%) ▲|CAT703.11+10.98 (+1.59%) ▲|CL92.53-0.58 (-0.62%) ▼|CMCSA22.00-0.05 (-0.23%) ▼|COF202.51+0.16 (+0.08%) ▲|COP149.88-1.49 (-0.98%) ▼|COST997.30-7.86 (-0.78%) ▼|CRM242.68-4.93 (-1.99%) ▼|CSCO110.34+0.10 (+0.09%) ▲|CVS92.46-0.07 (-0.08%) ▼|CVX230.49-1.52 (-0.66%) ▼|DE650.76+9.51 (+1.48%) ▲|DHR231.87-1.10 (-0.47%) ▼|DIS109.83-0.57 (-0.52%) ▼|DUK124.33-0.11 (-0.09%) ▼|EMR163.10+1.40 (+0.87%) ▲|FDX304.14+3.56 (+1.18%) ▲|GD355.79-1.25 (-0.35%) ▼|GE293.40+4.97 (+1.72%) ▲|GEV874.06+19.44 (+2.27%) ▲|GILD157.38-1.31 (-0.83%) ▼|GM80.10+3.79 (+4.96%) ▲|GOOG314.70+0.51 (+0.16%) ▲|GOOGL318.22+1.42 (+0.45%) ▲|GS911.06+17.78 (+1.99%) ▲|HD317.96-1.43 (-0.45%) ▼|HON217.21-2.07 (-0.94%) ▼|IBM250.80-2.64 (-1.04%) ▼|INTC92.22+1.75 (+1.93%) ▲|INTU330.60-9.29 (-2.73%) ▼|ISRG449.42-2.21 (-0.49%) ▼|JNJ267.30+1.00 (+0.38%) ▲|JPM336.32+2.28 (+0.68%) ▲|KO92.66-0.04 (-0.04%) ▼|LIN507.34-0.22 (-0.04%) ▼|LLY1,286.81+7.67 (+0.60%) ▲|LMT631.64-3.56 (-0.56%) ▼|LOW196.11-2.12 (-1.07%) ▼|LRCX237.11-0.40 (-0.17%) ▼|MA607.87-5.63 (-0.92%) ▼|MCD248.95-1.88 (-0.75%) ▼|MDLZ62.44-0.53 (-0.84%) ▼|MDT94.11-0.68 (-0.72%) ▼|META621.64-8.92 (-1.41%) ▼|MMM172.09-0.70 (-0.41%) ▼|MO73.20-0.43 (-0.58%) ▼|MRK140.82+0.21 (+0.15%) ▲|MS186.22+2.73 (+1.49%) ▲|MSFT528.97-3.63 (-0.68%) ▼|MU914.58+10.88 (+1.20%) ▲|NEE82.20+0.16 (+0.20%) ▲|NFLX63.06-0.85 (-1.32%) ▼|NKE37.74-0.17 (-0.45%) ▼|NOW154.24-3.94 (-2.49%) ▼|NVDA215.85-0.15 (-0.07%) ▼|ORCL129.92+3.86 (+3.06%) ▲|PEP134.52-0.94 (-0.69%) ▼|PFE29.72-0.08 (-0.25%) ▼|PG159.07-0.86 (-0.53%) ▼|PLTR197.40-1.44 (-0.72%) ▼|PM203.35+1.48 (+0.73%) ▲|QCOM179.64+0.04 (+0.02%) ▲|RTX196.97-0.52 (-0.26%) ▼|SBUX101.44-1.26 (-1.22%) ▼|SCHW89.59-0.14 (-0.16%) ▼|SO91.96-0.62 (-0.66%) ▼|SPG211.59-1.10 (-0.52%) ▼|T20.95+0.10 (+0.46%) ▲|TMO688.36+3.47 (+0.51%) ▲|TMUS146.97+0.04 (+0.03%) ▲|TSLA401.33+9.71 (+2.48%) ▲|TXN302.37+4.25 (+1.43%) ▲|UBER65.67-0.46 (-0.70%) ▼|UNH411.41+0.71 (+0.17%) ▲|UNP296.79-0.18 (-0.06%) ▼|UPS103.16+2.84 (+2.83%) ▲|USB59.23-0.48 (-0.80%) ▼|V399.42-4.74 (-1.17%) ▼|VZ43.27+0.17 (+0.39%) ▲|WFC82.30-0.36 (-0.43%) ▼|WMT119.23-1.06 (-0.88%) ▼|XOM182.01-2.53 (-1.37%) ▼|
12.3 C
New York
Tuesday, October 27, 2026

Tag: date

newsFORsourcecompanycontentinformation1releasesmarket

Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited

CONSHOHOCKEN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) (“Madrigal”) today announced that it has entered into an exclusive global license agreement with CSPC Pharmaceutical Group Limited (HKEX Stock CodeL 1093) (“CSPC”) for SYH2086, a preclinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist and orforglipron derivative. Madrigal plans to initiate clinical development in the first half of 2026.

Dimensional Fund Advisors Ltd. : Form 8.3 – TRITAX BIG BOX REIT PLC – Ordinary Shares

FORM 8.3

94 MW Vārme solar farm in Latvia reaches the commercial operation date

AB “Ignitis grupė” (hereinafter – the Group) informs that Vārme solar farm, controlled by its subsidiary UAB “Ignitis renewables” (hereinafter – Ignitis Renewables), has reached the commercial operation date (hereinafter – COD).

94 MW galios Varmės saulės parkas Latvijoje pasiekė komercinės veiklos pradžią

AB „Ignitis grupė“ (toliau – Grupė) informuoja, kad Varmės saulės parkas, kurį valdo jos dukterinė įmonė UAB „Ignitis renewables“ (toliau – „Ignitis renewables“), pasiekė komercinės veiklos pradžią (angl. commercial operation date, COD).

94 MW Vārme solar farm in Latvia reaches the commercial operation date

AB “Ignitis grupė” (hereinafter – the Group) informs that Vārme solar farm, controlled by its subsidiary UAB “Ignitis renewables” (hereinafter – Ignitis Renewables), has reached the commercial operation date (hereinafter – COD).

Aedifica NV/SA: 2025 half year financial report

Please find below Aedifica’s 2025 half year financial report.

Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules

JDE Peet’s reports half-year results 2025

Strong, broad-based performance across top-line, profitability and cash flow
FY 25 outlook raised

PRESS RELEASE

Amsterdam, July 30, 2025

Larimar Therapeutics Announces Pricing of Underwritten Public Offering

BALA CYNWYD, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the pricing of its previously announced underwritten public offering of 18,750,000 shares of its common stock at a price to the public of $3.20 per share. The aggregate gross proceeds to Larimar from this offering are expected to be $60.0 million, before deducting underwriting discounts and commissions and other offering expenses. In addition, Larimar has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 shares of its common stock at the public offering price, less underwriting discounts and commissions. All shares of common stock are being offered by Larimar. The offering is expected to close on or about July 31, 2025, subject to the satisfaction of customary closing conditions.

Meet the Finalists: TWOPAGES X Design Contest Public Vote Now Live

A 10th Anniversary Design Tribute, TWOPAGES Ushers in a New Chapter of Global Co-Creation 
A 10th Anniversary Design Tribute, TWOPAGES Ushers in a New Chapter of Global Co-Creation

Hydroleap Secures USD 4.75 million in Latest Funding Round to Accelerate Sustainable Water Technologies in APAC

SINGAPORE, July 30, 2025 /PRNewswire/ -- Hydroleap, a pioneering company in sustainable water treatment technologies, has successfully raised an additional USD 4.75 million in...

High Noon Announces Recall of its Vodka Seltzer Beach Pack (12 Pack) Due to Inclusion of CELSIUS® ASTRO VIBE™ Energy Drink Cans that were...

MODESTO, Calif., July 29, 2025 /PRNewswire/ -- High Noon is recalling two production lots of High Noon Beach Variety packs (12-pack/12 fluid ounce cans)....

J-Star Holding Announces Pricing of $5.0 Million Initial Public Offering

TAICHUNG CITY, Taiwan, July 29, 2025 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of applications including personal sports equipment, healthcare products, automobile parts, resin systems, and research and development services, today announced the pricing of its public offering of an aggregate 1,250,000 ordinary shares of the Company (the “Offering”). The offering is priced at $4.00 per share (the “Offering Price”).

Scout Drilling Results Extend Polymetallic Mineralization Footprints at Chita; Exploration Identifies Compelling Regional Targets

TSX-V: MSR TORONTO, July 29, 2025 /CNW/ - Minsud Resources Corp. (TSXV: MSR) ("Minsud" or the "Company"), is pleased to announce the significant results received from its...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDate

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers